Prescription Required
Aviglen MF Tablet is a dual-action medication comprised of Glibenclamide and Metformin, typically prescribed in the therapeutic treatment of type 2 diabetes..
Glibenclamide functions as a sulfonylurea, promoting insulin release, whereas Metformin works by enhancing insulin sensitivity and lowering glucose production within the liver. Combined, they provide a well-rounded approach to balancing blood sugar levels.
Adherence to the prescribed dosage, generally taken once daily after breakfast or the first significant meal is pivotal. The dosage may be calibrated based on individual patient response or blood glucose levels. Regular monitoring and compliance with the prescribed routine is essential for effective diabetes management.
While adverse effects might differ, common reactions include feelings of nausea, heartburn, and potential hypoglycemia. Severe effects, such as angioedema, can occur. It's crucial to notify all healthcare professionals of any side effects in a timely manner.
Care should be taken by those with allergies to these compounds, diabetic ketoacidosis, type 1 diabetes, glucose-6-phosphate dehydrogenase deficiency, or severe impairment of liver or kidney function. Pregnancy and breastfeeding should be approached with caution, and continuous monitoring is vital for anyone undergoing high-stress moments or medical procedures.
If a dose is forgotten, it should be taken as soon as it is remembered. However, if it's time for the subsequent dose, skip the missed dose, so as to avoid a double dosage.
Before using this product, seek guidance and assurance of safety from a medical professional.
Inadequate data available; discuss with your healthcare provider for individualized advice; potential harm to the infant should be considered.
Data is sparse; seek professional advice from your healthcare provider; potential dangers to the baby are present.
-Inform your doctor in case you have existing Kidney problems. -Provide information about your kidney condition while consulting.
Regularly assess liver function during the course of the treatment.
Glibenclamide operates like a glucose-regulating champion in dual methods. Initially, it obstructs specific paths in pancreatic cells, causing a transformation that discharges insulin. This aids in controlling blood glucose levels. Additionally, this influence isn't contained to the pancreas; it transpires in other regions of the body as well. Thus, the medication has a dual functionality, ensuring insulin is discharged not solely in the pancreas but also in other tissues. It's akin to a superhero overseeing glucose level regulation from diverse perspectives.
Type 2 diabetes mellitus is a chronic condition that affects how the body regulates and uses sugar (glucose) as a fuel. It occurs when the body becomes resistant to insulin, a hormone that helps glucose enter the cells, or when the pancreas cannot produce enough insulin. As a result, the blood sugar levels become too high and can cause damage to various organs and tissues.
Content Updated on
Saturday, 27 January, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA